A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer

Conditions: Breast Neoplasm Female Interventions: Drug: Docetaxel; Drug: Carboplatin; Drug: Inetetamab; Drug: Pyrotinib Sponsors: Wang Ouchen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials